Results 11 to 20 of about 38,036 (299)

An introduction to adverse drug reaction reporting systems in different countries

International Journal of Pharmacy Practice, 2005
Abstract Objective To review adverse drug reaction (ADR) reporting schemes in selected developed countries, with emphasis on identifying community pharmacists' roles in ADR reporting. Setting International comparison between eight ...
Reza, S.M.R., Emmerton, L.M.
openaire   +4 more sources

Characterizing and Comparing Adverse Drug Events Documented in 2 Spontaneous Reporting Systems in the Lower Mainland of British Columbia, Canada: Retrospective Observational Study

JMIR Human Factors
BackgroundRobust adverse drug event (ADE) reporting systems are crucial to monitor and identify drug safety signals, but the quantity and type of ADEs captured may vary by system characteristics.
Erica Y Lau, Amber Cragg, Serena S Small, Katherine Butcher, Corinne M Hohl   +4 more
doaj   +2 more sources

Do community pharmacists in Nepal have a role in adverse drug reaction reporting systems? [PDF]

Australas Med J, 2013
Community pharmacies in Nepal serve both rural and urban populations and are an integral part of the Nepalese healthcare system. These community pharmacies are run by non-pharmacist professionals with orientation training on pharmacology and drug ...
K C B, Alrasheedy AA, Ibrahim MI.
europepmc   +2 more sources

Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database

Frontiers in Oncology, 2021
IntroductionAdverse drug reactions (ADRs) in pediatric cancer patients have not yet received due attention in the world. Antineoplastic drugs are frequently related to ADRs.
Zhiming Jiao, Zhanchun Feng, Ziqi Yan, Jinwen Zhang, Gang Li, Ganyi Wang, Ganyi Wang, Qianyu Wang, Da Feng   +8 more
doaj   +1 more source

The use of transpulmonary contrast echocardiography: A first experience in Serbia [PDF]

Vojnosanitetski Pregled, 2021
Background/Aim. Contrast echocardiography (CE) is an echocardiographic modality where ultrasound contrast echocardiographic agent (CEA) is introduced peripherally for the image enhancement.
Stojšić-Milosavljević Anastrazija, Ilić Aleksandra, Stojšić Snežana, Ivanović Vladimir, Milićević Jelena, Kovač Robert, Stefanović Maja, Tadić Snežana, Miljković Tatjana, Bjelobrk Marija, Dabović Dragana, Živkov-Šaponja Dragoslava, Petrović Milovan, Aleksandar Redžek   +13 more
doaj   +1 more source

Nurses as adverse drug reaction reporting advocates [PDF]

, 2022
Adverse drug reactions (ADRs) is a challenge in modern healthcare, particularly given the increasing complexity of drug therapy, an ageing population, rising multimorbidity, and a high patient turnover.
Pettersen, Trond Røed, Andreassen, Lillan Mo, Schjøtt, Jan Didrik, Bjånes, Tormod Karlsen   +3 more
core   +1 more source

A comparative study of active and passive adverse drug reaction reporting systems in terms of false reporting rate [PDF]

Scripta Medica, 2020
Background: World Health Organisation Uppsala Monitoring Centre (WHO-UMC) was set up in 1968 to collect Adverse Drug Reactions (ADRs) periodically for all drugs across the globe.
Bansal Alka, Agrawal Ashish, Sharma Lokendra, Jain Smita   +3 more
doaj  

Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys [PDF]

, 2011
Background: The monitoring of adverse drug reactions (ADRs) through pharmacovigilance is vital to patient safety. Spontaneous reporting of ADRs is one method of pharmacovigilance, and in the UK this is undertaken through the Yellow Card Scheme (YCS ...
DJ McLernon, Murphy, E., Fortnum, H, Watson, M C, McLernon, D.J., Hazell, L, Gifford, A., MC Watson, Fortnum, H., Watson, M.C., Bond, C. M., Lee, A.J., Avery, A J, Bond, Christine, Hannaford, P.C., Krska, Janet, Watson, M. C., Avery, Anthony, J Krska, Krska, J, Mclernon, David J., Hannaford, P C, Shakir, S., Lee, A J, Lee, A. J., Gifford, A, Murphy, E, CM Bond, E Murphy, L Hazell, Hazell, L., Gifford, Alison, Watson, Margaret C., A Gifford, H Fortnum, AJ Avery, Bond, C.M., C Anderson, Anderson, C., Anderson, C, S Shakir, McLernon, D. J., McLernon, D J, Anderson, Claire, Bond, C M, Fortnum, Heather, Shakir, S, Avery, A. J., PC Hannaford, Murphy, Elizabeth, Hannaford, P. C., Hannaford, Philip C., AJ Lee, Krska, J.   +53 more
core   +1 more source

Completeness of adverse drug reactions reports of the Saudi adverse event reporting system

Saudi Medical Journal, 2015
To assess completeness of reports in the Saudi Adverse Event Reporting System (SAERS), which is a part of the Saudi Food and Drug Authority pharmacovigilance system for monitoring the safety of medications.A cross-sectional study was conducted in Riyadh, Saudi Arabia using the reports that were received between December 2009 and June 2012 in the SAERS.
Alshammari, Thamir M., Al-Kathiri, Wa’ad H., Louet, Hervé Le, Aljadhey, Hisham S.   +3 more
openaire   +2 more sources

Determinants of signal selection in a spontaneous reporting system for adverse drug reactions [PDF]

British Journal of Clinical Pharmacology, 2001
Aims  Detection of new adverse drug reactions (ADR) after marketing is often based on a manual review of reports sent to a Spontaneous Reporting System (SRS). Among the many potential signals that are identified, only a limited number are important enough to require further attention.
van Puijenbroek, E.P., van Grootheest, K., Diemont, W.L., Leufkens, H.G.M., Egberts, A.C.G.   +4 more
openaire   +5 more sources